Moleculin Biotech, Inc. — Director's Dealing 2023

May 26, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2023-05-25

Reporting Person: Cermak Elizabeth (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-25	Stock option (right to buy)	$0.62	A	15000	Acquired	2033-05-25	Common Stock (15000)	Direct

Footnotes

F1: The options set forth in this table vest on the earlier of one year from the date of the Company's 2023 annual meeting of stockholders or on the next annual meeting of stockholders, subject to the grantee's continued service on the Company's Board of Directors on such vesting date.

F2: The options were issued in connection with the reporting person's Board of Director service to the Company.